Baseline Characteristics of Patients Diagnosed with Systemic Lupus Erythematosus Initiating Treatment with Intravenous Belimumab

被引：0
|
作者：
Bell, Christopher F. [1 ]
Priest, Julie [1 ,2 ,3 ]
Amelio, Justyna [4 ]
Song, Xue [5 ]
Kan, Hong [6 ]
Stott-Miller, Marni [7 ]
Limone, Brendan [5 ]
Noxon, Virginia [5 ]
Costenbader, Karen H. [8 ,9 ]
机构：
[1] GSK US Value Evidence & Outcomes, Res Triangle Pk, NC USA
[2] US Hlth Outcomes, Durham, NC USA
[3] ViiV Healthcare, Durham, NC USA
[4] GSK Real World Evidence & Epidemiol, Stevenage, Herts, England
[5] Truven Hlth Analyt, Ann Arbor, MI USA
[6] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA
[7] GSK Real World Evidence & Epidemiol, Uxbridge, Middx, England
[8] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA
[9] Harvard Med Sch, Boston, MA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2593
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Belimumab for children with systemic lupus erythematosus
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2020, 2 (09): : E526 - E526
  • [32] Belimumab Therapy in Systemic Lupus Erythematosus
    Zouali, Moncef
    Uy, Eugene A.
    BIODRUGS, 2013, 27 (03) : 225 - 235
  • [33] Belimumab for the management of systemic lupus erythematosus
    Lutalo, Pamela M. K.
    D'Cruz, David P.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (07) : 957 - 963
  • [34] Belimumab (Benlysta) for Systemic Lupus Erythematosus
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2011, 53 (1366): : 45 - 46
  • [35] Belimumab: A Review in Systemic Lupus Erythematosus
    Hannah A. Blair
    Sean T. Duggan
    Drugs, 2018, 78 : 355 - 366
  • [36] Belimumab: A Review in Systemic Lupus Erythematosus
    Blair, Hannah A.
    Duggan, Sean T.
    DRUGS, 2018, 78 (03) : 355 - 366
  • [37] EFFICACY OF BELIMUMAB TREATMENT FOR SYSTEMIC LUPUS ERYTHEMATOSUS AT OUR HOSPITAL
    Mizusaki, M.
    Wakiya, R.
    Nakashima, S.
    Shimada, H.
    Sugihara, K.
    Kato, M.
    Miyagi, T.
    Ushio, Y.
    Mino, R.
    Chujo, K.
    Kameda, T.
    Dobashi, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1347 - 1347
  • [38] Belimumab: First targeted biological treatment for systemic lupus erythematosus
    Dubey, Ashok K.
    Handu, Shailendra S.
    Dubey, Suparna
    Sharma, Prashant
    Sharma, K. K.
    Ahmed, Qazi M.
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2011, 2 (04) : 317 - 319
  • [39] Efficacy of a sequential treatment by belimumab in monogenic systemic lupus erythematosus
    Akbar, Lujayn
    Alsagheir, Razan
    Al-Mayouf, Sulaiman M.
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2020, 7 (04) : 184 - 189
  • [40] Systemic lupus erythematosus exacerbation following cessation of belimumab treatment
    Furer, V.
    Zisman, D.
    Pokroy-Shapira, E.
    Molad, Y.
    Elkayam, O.
    Paran, D.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 (02) : 103 - 106
12345